These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 4678127

  • 1. [Comparative pharmacokinetic studies on fenoterol-hydrobromide in rat, dog and man].
    Rominger KL, Pollmann W.
    Arzneimittelforschung; 1972 Jul; 22(7):1190-6. PubMed ID: 4678127
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on distribution and passage of tritium labelled fenoterol-hydrobromide (Th 1165a) in gravid and lactating rabbits].
    Meissner J, Preil P.
    Arzneimittelforschung; 1974 Aug; 24(8):1213-7. PubMed ID: 4153682
    [No Abstract] [Full Text] [Related]

  • 3. Determination of bioavailability on the basis of tachycardia after intravenous and oral administration of fenoterol, orciprenaline and salbutamol in non-anaesthetized rats.
    Muacevic G.
    Arzneimittelforschung; 1985 Aug; 35(1A):406-8. PubMed ID: 2859035
    [Abstract] [Full Text] [Related]

  • 4. [Whole-body autoradiographic studies on the distribution and the placental transfer of fenoterol-hydrobromide (Th 1165a) in rats].
    Kramer I, Klingspohr HJ.
    Arzneimittelforschung; 1974 Aug; 24(8):1210-3. PubMed ID: 4153844
    [No Abstract] [Full Text] [Related]

  • 5. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetic studies on H3-digoxin and H3-lanatosid in man].
    Dengler HJ, Bodem G, Wirth K.
    Arzneimittelforschung; 1973 Jan; 23(1):64-74. PubMed ID: 4740698
    [No Abstract] [Full Text] [Related]

  • 7. Renal and gastrointestinal excretion of ouabain in dog and man.
    Selden R, Margolies MN, Smith TW.
    J Pharmacol Exp Ther; 1974 Mar; 188(3):615-23. PubMed ID: 4816328
    [No Abstract] [Full Text] [Related]

  • 8. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
    Clay MP, Hanssen BR, Surapaneni SS, Lindstrom TD.
    Chirality; 1999 Mar; 11(3):233-40. PubMed ID: 10079502
    [Abstract] [Full Text] [Related]

  • 9. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 10. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetic studies on helveticosol acetonide in man].
    Zielske F, Dovidat H, Betzien G, Voigtländer W.
    Arzneimittelforschung; 1971 Apr; 21(4):566-71. PubMed ID: 5108163
    [No Abstract] [Full Text] [Related]

  • 12. Absorption, distribution and excretion of alprenolol in man, dog and rat.
    Bodin NO, Borg KO, Johansson R, Obianwu H, Svensson R.
    Acta Pharmacol Toxicol (Copenh); 1974 Oct; 35(4):261-9. PubMed ID: 4479578
    [No Abstract] [Full Text] [Related]

  • 13. [Pharmacokinetic studies on 14C-azapropazone dihydrate in the rat].
    Klatt L, Koss FW.
    Arzneimittelforschung; 1973 Jul; 23(7):913-9. PubMed ID: 4800443
    [No Abstract] [Full Text] [Related]

  • 14. Bioavailability of indomethacin in man.
    Baer JE, Hucker HB, Duggan DE.
    Ann Clin Res; 1974 Jul; 6(0):suppl 11:44-7. PubMed ID: 4211834
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C, Nolan RJ.
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [Abstract] [Full Text] [Related]

  • 16. Salicylate pharmacokintics in the dog.
    McCann WP, Palmisano PA.
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):17-25. PubMed ID: 4686099
    [No Abstract] [Full Text] [Related]

  • 17. Propylthiouracil: absorption, metabolism and excretion in the albino rat.
    Sitar DS, Thornhill DP.
    J Pharmacol Exp Ther; 1972 Nov; 183(2):440-8. PubMed ID: 5083555
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacokinetic studies on triatiated aescin in the mouse and rat].
    Lang W, Mennicke WH.
    Arzneimittelforschung; 1972 Nov; 22(11):1928-32. PubMed ID: 4679067
    [No Abstract] [Full Text] [Related]

  • 19. Disposition of the opioid antagonist, LY255582, in rats and dogs.
    Swanson SP, Catlow J, Pohland RC, Chay SH, Johnson T.
    Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
    [Abstract] [Full Text] [Related]

  • 20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA.
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.